E-DRUG: Call for Papers: JoPPP Special Series on COVID-19
--------------------------------------------------------------
Dear E-druggers
The Journal of Pharmaceutical Policy and Practice (JoPPP) is announcing a " Call for Papers for a special series on COVID-19".
Kindly see the details below. I will appreciate if you could kindly circulate this announcement among your circles.
Call for Papers: JoPPP Special Series on COVID-19
Given the current situation, the Journal of Pharmaceutical Policy and Practice (JoPPP) would like to announce a Call for Papers for a special series on COVID-19.
This includes issues related to prevention, newer treatments, medicines safety, medicines quality and shortages, pharmaceutical policy and practice, pharmacists and pharmacy services, information and dissemination, as well as technology aspects of COVID-19.
Submissions are welcome on the following topics:
* Pharmacists and pharmacy services
* Medicines use and safety aspects of investigational medicines including antivirals, antimalarials, chloroquine, hydroxychloroquine, and other medicines
* Importance of reliable independent sources of information with regards to prevention, treatment, and medicines use
* The role of technology and pharmacy services
* Pharmacists’ response towards COVID-19, including prevention, mitigation, treatment, and the role of pharmacy services
* Medicines safety, quality, and shortages
* Country-specific case studies on pharmacy and COVID-19
Stay safe and stay blessed!
Kind Regards
Zaheer
Professor Zaheer-Ud-Din Babar BPharm MPharm PhD SFHEA
Professor in Medicines and Healthcare
Director, Centre for Pharmaceutical Policy and Practice Research
Department of Pharmacy, University of Huddersfield, Queensgate, HD1 3DH
Huddersfield, United Kingdom
Editor-in-Chief
Journal of Pharmaceutical Policy and Practice
Zaheer Babar <Z.Babar@hud.ac.uk>